EMLA Cream as Analgesic for Outpatient Gynecological Procedures

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Pain

In brief

The goal of this clinical trial is to compare pain perception in the study participant population undergoing the following gynecological procedures: Intra Uterine Device (IUD) insertion, hysteroscopy, and endometrial biopsy and given either Eutectic Mixture of Local Anesthetics (EMLA) cream or a placebo. The main question to answer is: • Does EMLA cream reduce pain when administered during the following gynecological procedures: IUD insertion, hysteroscopy, and endometrial biopsy? Participants will be asked to do assess their pain on the Visual Analogue Scale through 3 times during the procedure. Researchers will compare the study group with those receiving placebo group to see if there is a difference in pain scores.

Key facts

Study ID

NCT05970354

Run by

CAMC Health System

People needed

400

Starts

2023-09-15

Expected to finish

2025-02-28

Last updated by the study team

2024-08-01

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Patient will undergo one of the following procedures: intra-uterine device insertion, hysteroscopy, or endometrial biopsies

You may not qualify if…

• Known hypersensitivity to amide anesthetics
• Pre-existing methemoglobinemia

Where it is running

• Charleston Area Medical Center Institute for Academic Medicine — Charleston, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.